Podcast by Dom Cooke to explore big businesses, Business Breakdowns

Business Breakdowns

Podcast by Dom Cooke to explore big businesses

Learn how companies work from the people who know them best. We do deep research and interview industry veterans, investment professionals, and corporate executives to explain the inner workings of public stocks and private businesses. For each company, we break down their history, business model, financial statements, secret sauce, and bull/bear case. We believe every business has lessons to teach us and Breakdowns is here to highlight them. Learn more and stay up to date at www.joincolossus.com.

Equity Bottom-Up

<ul><li>Agilent is a leading provider of instruments, services, and consumables for labs in the life sciences, diagnostics, applied chemical markets, and R&amp;D sectors</li><li>With a market cap of $30 billion, Agilent was born within Hewlett Packard and spun off more than 25 years ago</li><li>Agilent has a total addressable market of $160 billion and has a history dating back to 1938, starting as a testing instrument for audio equipment used by Disney in the production of Fantasia</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.</em></p>

Agilent is a leading provider of instruments, services, and consumables for labs in the life sciences, diagnostics, applied chemical markets, and R&amp;D sectorsWith a market cap of $30 billion, Agilent was born within Hewlett Packard and spun off more than 25 years agoAgilent has a total addressable market of $160 billion and has a history dating back to 1938, starting as a testing instrument for audio equipment used by Disney in the production of FantasiaThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Agilent: Back To The Lab - [Business Breakdowns, EP.223]

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

<ul><li>Agilent Technologies, Inc. reported its second quarter of fiscal year 2025 results with a strong performance, achieving revenue of $1.67 billion, marking a 6% increase on a reported basis and 5.3% on a core basis compared to the second quarter of 2024.</li><li>The company's operating margin was at 25.1%, and earnings per share (EPS) grew by 7% to $1.31, exceeding expectations and continuing its trend of accelerating growth for the fourth consecutive quarter.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Agilent Technologies, Inc. reported its second quarter of fiscal year 2025 results with a strong performance, achieving revenue of $1.67 billion, marking a 6% increase on a reported basis and 5.3% on a core basis compared to the second quarter of 2024.The company's operating margin was at 25.1%, and earnings per share (EPS) grew by 7% to $1.31, exceeding expectations and continuing its trend of accelerating growth for the fourth consecutive quarter.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Agilent Technologies' Hidden Growth Engine: How New Acquisitions Are Shaping the Future of Modern Medicine!

<ul><li>Agilent Technologies' earnings for the first quarter of fiscal year 2025 highlighted a solid start to the year, with the company exceeding expectations for core revenue growth and earnings per share (EPS).</li><li>The company's revenue for the quarter was $1.681 billion, a 1% increase year-over-year, driven by strong performance in various sectors and regions, particularly in PFAS (per- and polyfluoroalkyl substances) and the China stimulus awards.</li><li>The company experienced growth in all regions except academia and government.</li></ul>

Agilent Technologies' earnings for the first quarter of fiscal year 2025 highlighted a solid start to the year, with the company exceeding expectations for core revenue growth and earnings per share (EPS).The company's revenue for the quarter was $1.681 billion, a 1% increase year-over-year, driven by strong performance in various sectors and regions, particularly in PFAS (per- and polyfluoroalkyl substances) and the China stimulus awards.The company experienced growth in all regions except academia and government.

Agilent Technologies: How NASD and The New Demand Dynamics Are Shaping Its Future!

<ul><li>Agilent Technologies, Inc. recently reported its fourth quarter results for fiscal year 2024.</li><li>The company generated revenues of $1.701 billion, marking roughly 1% growth in reported figures, with core growth remaining flat despite challenging market conditions.</li><li>Notably, Agilent's total company book-to-bill ratio exceeded one, indicating a steady market recovery and positioning for continued improvement into 2025.</li></ul>

Agilent Technologies, Inc. recently reported its fourth quarter results for fiscal year 2024.The company generated revenues of $1.701 billion, marking roughly 1% growth in reported figures, with core growth remaining flat despite challenging market conditions.Notably, Agilent's total company book-to-bill ratio exceeded one, indicating a steady market recovery and positioning for continued improvement into 2025.

Agilent Technologies: Pharma Market Expansion As A Key Growth Catalyst! - Major Drivers

<ul><li>Agilent Technologies showed resilience in its Q3 2024 earnings, despite facing challenges with a 4.4% revenue decline and continued pressure in sectors like biopharma.</li><li>The company reported $1.578 billion in revenues and an earnings per share (EPS) of $1.32, surpassing the upper end of its guidance by $0.04.</li><li>This performance highlights robust operational management and strategic agility in an environment where many sectors are facing budget constraints.</li></ul>

Agilent Technologies showed resilience in its Q3 2024 earnings, despite facing challenges with a 4.4% revenue decline and continued pressure in sectors like biopharma.The company reported $1.578 billion in revenues and an earnings per share (EPS) of $1.32, surpassing the upper end of its guidance by $0.04.This performance highlights robust operational management and strategic agility in an environment where many sectors are facing budget constraints.

Agilent Technologies: A Tale Of Geographic Diversification and Emerging Market Growth! - Major Drivers

United States

Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences, and chemical analysis industries. The Company offers electronic and bio-analytical measurement, semiconductor, and board testing.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Agilent Technologies (A US)

Agilent: Back To The Lab - [Business Breakdowns, EP.223]

Agilent is a multi-billion dollar company that offers instruments, services, and consumables for laboratories, with a long history dating back to...

Business Breakdowns

Agilent Technologies' Hidden Growth Engine: How New Acquisitions Are Shaping the Future of Modern Medicine!

Agilent Technologies, Inc. reported its second quarter of fiscal year 2025 results with a strong performance, achieving revenue of $1.67 billion,...

Baptista Research

Agilent Technologies: How NASD and The New Demand Dynamics Are Shaping Its Future!

Agilent Technologies' earnings for the first quarter of fiscal year 2025 highlighted a solid start to the year, with the company exceeding...

Baptista Research

Agilent Technologies: Pharma Market Expansion As A Key Growth Catalyst! - Major Drivers

Agilent Technologies, Inc. recently reported its fourth quarter results for fiscal year 2024. The company generated revenues of $1.701 billion,...

Baptista Research

Agilent Technologies: A Tale Of Geographic Diversification and Emerging Market Growth! - Major Drivers

Agilent Technologies showed resilience in its Q3 2024 earnings, despite facing challenges with a 4.4% revenue decline and continued pressure in...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)